Richard Suderman is the co-founder and Director of R&D at Nectagen, Inc. , a biotech company developing antibody mimetics known as nanoCLAMPs. His work focuses on creating novel therapeutics for infectious diseases. He holds a Ph. D. in Biochemistry from Kansas State University and previously worked as a Project Engineer for Koch Industries.
Outside of his primary research, Richard maintains strong ties to the academic community in Kansas. He is an alumnus of Kansas State University and has shown interest in local healthcare institutions, such as the University of Kansas Medical Centers nursing program.
His career began in industrial process engineering before he pivoted to biochemistry and co-founded a biotech firm.
Richard Suderman
Director, Research and Development and Co-founder at Nectagen, Inc.
Shawnee, Kansas, United States
Overview
Topics They Care About
Antibody Mimetics
He co-founded Nectagen to develop and commercialize "nanoCLAMPs, " a proprietary antibody mimetic technology used for research, purification, and therapeutics.
Infectious Disease Therapeutics
His recent work includes developing nanoCLAMPs for intranasal protection against SARS-CoV-2 and to neutralize toxins from C. difficile bacteria.
Biotech Entrepreneurship
He is the co-founder of Nectagen (formerly Aptakon, Inc. ), leading its research and development since its inception in 2007.
Media Appearances
Richard has no verified media appearances
Work History
Director, Research and Development and Co-founder at Nectagen, Inc.
5-2008
Scientist and Co-Founder at Nectagen, Inc., (formerly Aptakon, Inc.)
5-2008
Post-doctoral Fellow at University of Georgia
Graduate Student at Kansas State University
Project Engineer at Koch Industries
Education
1989 - 2004
B.S. from Kansas State University
More Information
Social Presence :
Prographics :
Exp : 17
Location : Shawnee, Kansas, United States
Job Level : Leadership
Designation : Director, Research and Development and Co-founder at Nectagen, Inc.
